Hh Signaling Antagonist VII, JK184
CAS: 315703-52-7
Ref. 3D-QMA70352
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
- Jk184
Hh Signaling Antagonist VII, JK184 is a polymerase chain reaction (PCR) primer that was designed to detect the Hh signaling pathway in muscle cells. It has been shown to be effective in treating muscle diseases such as muscular dystrophy and Duchenne muscular dystrophy. The Hh signaling antagonist has also been shown to promote the differentiation of pluripotent stem cells into muscle cells and reduce the size of metastatic pancreatic cancer tumors by inhibiting tumor growth. This drug also has an effect on glucose regulation and diabetic neuropathy, including transcriptional regulation, cell growth, and biological function.
Chemical properties
Technical inquiry about: 3D-QMA70352 Hh Signaling Antagonist VII, JK184
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
